✦ LIBER ✦

Reducing Disruptive Behavior of a Group-Home Resident with Autism and Mental Retardation

✍ Scribed by R. Matthew Reese; James A. Sherman; Jan B. Sheldon

Book ID: 111556629
Publisher: Springer US
Year: 1998
Tongue: English
Weight: 825 KB
Volume: 28
Category: Article
ISSN: 1573-3432
DOI: 10.1023/a:1026096700607

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reducing agitated—Disruptive behavior of

Reducing agitated—Disruptive behavior of mentally retarded residents of community group homes: The role of self-recording and peer-prompted self-recording

✍ Reese, R.Matthew; Sherman, James A.; Sheldon, Jan 📂 Article 📅 1984 🏛 Elsevier Science ⚖ 895 KB

The modification of disruptive behaviors

The modification of disruptive behaviors by a group of trainable mentally retarded adults

✍ Michael Klein; Robert J. Paluck; Patricia Beresford 📂 Article 📅 1976 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Behavioral Treatment of Children With Au

Behavioral Treatment of Children With Autism, Mental Retardation, and Related Disabilities: Ethics and Efficacy

✍ Jennifer Harrison Elder 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 765 KB

An analysis of maladaptive behaviors in

An analysis of maladaptive behaviors in persons with autism, PDD-NOS, and mental retardation

✍ Jennifer E Dawson; Johnny L Matson; Katie E Cherry 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Health characteristics and behaviors of

Health characteristics and behaviors of adults with mental retardation residing in three living arrangements

✍ James H. Rimmer; David Braddock; Beth Marks 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 583 KB

Psychopharmacology of mood disorders in

Psychopharmacology of mood disorders in persons with mental retardation and autism

✍ Hellings, Jessica A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views

The ever-growing range of designer drugs such as selective serotonin reuptake inhibitors (SSRIs) and other new antidepressants, atypical antipsychotic agents, and antiseizure medications may improve treatment efficacy and safety for persons with mood disorders and mental retardation (MR) and autism.